Search

Displaying results 7161 - 7170 of 10000 in total
  1. Drug

    Selenomethionine Se-75

    go.drugbank.com/drugs/DB09400
    Approved

    Categories: Amino Acids, Peptides, and Proteins
  2. Drug

    NCX 1022

    go.drugbank.com/drugs/DB05410
    Experimental

    NCX is an NO-releasing derivative of hydrocortisone.

    Categories: Hormones, Hormone Substitutes, and Hormone Antagonists
  3. Drug

    Pimonidazole

    go.drugbank.com/drugs/DB12485
    Investigational

    Pimonidazole is under investigation for the diagnostic of Prostate Cancer and Head and Neck Cancer.

  4. Drug

    CVT-6883

    go.drugbank.com/drugs/DB05936
    Experimental

    and fibrosis. … CVT-6883 is a selective, potent and orally available A2B-adenosine receptor antagonist which CV Therapeutics is investigating for the potential treatment of asthma and other conditions related to inflammation

  5. Drug

    MVR-T3011

    go.drugbank.com/drugs/DB17378
    Investigational

    MVR-T3011 is a genetically modified oncolytic Herpes Simplex Virus (HSV-1) with 2 exogenous genes encoding the active heterodimer human interleukin 12 (IL-12) and the Fab fragment of an anti-human PD-1

  6. Drug

    Pemrametostat

    go.drugbank.com/drugs/DB19170
    Investigational

    Pemrametostat is under investigation in clinical trial NCT03614728 (Study to Investigate the Safety and Clinical Activity of GSK3326595 and Other Agents to Treat Myelodysplastic Syndrome (MDS) and Acute

  7. Drug

    AMGN-0007

    go.drugbank.com/drugs/DB06511
    Experimental

    Recombinant osteoprotegerin (AMGN-0007) is a recombinant OPG construct developed as a potential therapeutic agent in the treatment of bone disease.

    Categories: Amino Acids, Peptides, and Proteins
  8. Drug

    Proflavine

    go.drugbank.com/drugs/DB01123
    ApprovedInvestigational

    3,6-Diaminoacridine. Topical antiseptic used mainly in wound dressings.

  9. Drug

    PF-06260414

    go.drugbank.com/drugs/DB15221
    Investigational

    PF-06260414 is under investigation in clinical trial NCT02070939 (Study To Evaluate Safety And Tolerability Of Single And Multiple Ascending Doses Of PF- 06260414 In Healthy Western And Japanese Male Subjects

  10. Drug

    Casopitant

    go.drugbank.com/drugs/DB06634
    Investigational

    Categories: Alimentary Tract and Metabolism, Antiemetics and Antinauseants